Average annual cost of Parkinson’s disease in São Paulo, Brazil, with a focus on disease-related motor symptoms

References

• DorseyERConstantinescuRThompsonJPProjected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology200668538438617082464
   PubMed Web of Science ®Google Scholar
• Andlin-SobockiPJönssonBWittchenHUOlesenJCost of disorders of the brain in EuropeEur J Neurol200512Suppl 1127
   PubMed Web of Science ®Google Scholar
• de LauLMLBretelerMMBEpidemiology of Parkinson’s diseaseLancet Neurology20065652553516713924
   PubMed Web of Science ®Google Scholar
• AlvesGForsaaEBPedersenKFGjerstadMDLarsenJPEpidemiology of Parkinson’s diseaseJ Neurol2008255Suppl 5183218787879
   PubMed Web of Science ®Google Scholar
• BausoDJTartariJPStefaniCVRojasJIGiuntaDHCristianoEIncidence and prevalence of Parkinson’s disease in Buenos Aires City, ArgentinaEur J Neurol20121981108111322390275
   PubMed Web of Science ®Google Scholar
• von CampenhausenSWinterYRodrigues e SilvaACosts of illness and care in Parkinson’s Disease: an evaluation in six countriesEur Neuropsychopharmacol201121218019120888737
   PubMed Web of Science ®Google Scholar
• FindleyLJThe economic impact of Parkinson’s diseaseParkinsonism Relat Disord200713SupplS8S1217702630
   PubMed Web of Science ®Google Scholar
• McCronePAllcockLMBurnDJPredicting the cost of Parkinson’s diseaseMov Disord200722680481217290462
   PubMed Web of Science ®Google Scholar
• ZhaoYJTanLCSAuWLEstimating the lifetime economic burden of Parkinson’s disease in SingaporeEur J Neurol201320236837422978629
   PubMed Web of Science ®Google Scholar
• BovolentaTMde Azevedo SilvaSMArb SabaRBorgesVFerrazHBFelicioACSystematic review and critical analysis of cost studies associated with Parkinson’s diseaseParkinson’s Dis20172017341094628357150
   PubMed Web of Science ®Google Scholar
• ZhaoYJTanLCSLiSCEconomic burden of Parkinson’s disease in SingaporeEur J Neurol201118351952620840378
   PubMed Web of Science ®Google Scholar
• JohnsonSJKaltenboeckADienerMCosts of Parkinson’s disease in a privately insured populationPharmacoeconomics201331979980623907717
   PubMed Web of Science ®Google Scholar
• HoehnMMYahrMDParkinsonism: onset, progression, and mortality. 1967Neurology1998502318 and 16 pages following9484345
   PubMed Web of Science ®Google Scholar
• DowdingCHShentonCLSalekSSA review of the health-related quality of life and economic impact of Parkinson’s diseaseDrugs Aging200623969372117020395
   PubMed Web of Science ®Google Scholar
• BolandDFStacyMThe economic and quality of life burden associated with Parkinson’s disease: a focus on symptomsAm J Manag Care2012187 SupplS168S17523039865
   PubMed Web of Science ®Google Scholar
• DuncanGWKhooTKYarnallAJHealth-related quality of life in early Parkinson’s disease: the impact of nonmotor symptomsMov Disord201429219520224123307
   PubMed Web of Science ®Google Scholar
• Martinez-MartinPRodriguez-BlazquezCKurtisMMChaudhuriKRGroup NVThe impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s diseaseMov Disord201126339940621264941
   PubMed Web of Science ®Google Scholar
• LiHZhangMChenLNonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson’s diseaseMov Disord201025162740274620945434
   PubMed Web of Science ®Google Scholar
• ReeseJPDamsJWinterYBalzer-GeldsetzerMOertelWHDodelRPharmacoeconomic considerations of treating patients with advanced Parkinson’s diseaseExpert Opin Pharmacother201213793995822475391
   PubMed Web of Science ®Google Scholar
• GibbWRLeesAJThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s diseaseJ Neurol Neurosurg Psychiatry19885167457522841426
   PubMed Web of Science ®Google Scholar
• KeranenTKaakkolaSSotaniemiKEconomic burden and quality of life impairment increase with severity of PDParkinsonism Relat Disord20039316316812573872
   PubMed Web of Science ®Google Scholar
• TamásGGulácsiLBereczkiDQuality of life and costs in Parkinson’s disease: a cross sectional study in HungaryPLoS One201499e10770425229404
   PubMed Web of Science ®Google Scholar
• AltmanDGPractical Statistics for Medical Research1st edLondonChapman & Hall/CRC1991
   Google Scholar
• IBM CorpISSfW, Version 24.0Armonk, NYIBM Corp2016
   Google Scholar
• R Core TeamR: a language and environment for statistical computingR Foundation for Statistical Computing VAustria2015 Available from: http://www.R-project.org/Accessed July 25, 2016
   Google Scholar
• Rodríguez-BlázquezCForjazMJLizáLPazSMartínez-MartínPEstimating the direct and indirect costs associated with Parkinsons diseaseExpert Rev Pharmacoecon Outcomes Res201515688991126511768
   PubMed Web of Science ®Google Scholar
• VargasAPCarod-ArtalFJNunesSSMeloMDisability and use of healthcare resources in Brazilian patients with Parkinson’s diseaseDisabil Rehabil200830141055106218953751
   PubMed Web of Science ®Google Scholar
• WinterYvon CampenhausenSReeseJPCosts of Parkinson’s disease and antiparkinsonian pharmacotherapy: an Italian cohort studyNeurodegener Dis20107636537220523028
   PubMed Web of Science ®Google Scholar
• VossiusCGjerstadMBaasHLarsenJPDrug costs for patients with Parkinson’s disease in two different European countriesActa Neurol Scand2006113422823216542161
   PubMed Web of Science ®Google Scholar
• CussoMEDonaldKJKhooTKThe impact of physical activity on non-motor symptoms in Parkinson’s disease: a systematic reviewFront Med (Lausanne)201633527583249
   PubMed Web of Science ®Google Scholar
• RedeckerCBilsingACsotiIPhysiotherapy in Parkinson’s disease patients: Recommendations for clinical practiceBasal Ganglia2014413538
   Google Scholar
• SchragABanksPTime of loss of employment in Parkinson’s diseaseMov Disord200621111839184316941456
   PubMed Web of Science ®Google Scholar
• WinterYBalzer-GeldsetzerMSpottkeALongitudinal study of the socioeconomic burden of Parkinson’s disease in GermanyEur J Neurol20101791156116320345926
   PubMed Web of Science ®Google Scholar
• SpottkeAEReuterMMachatOCost of illness and its predictors for Parkinson’s disease in GermanyPharmacoeconomics200523881783616097843
   PubMed Web of Science ®Google Scholar
• Brazil. [Presidência da República. Lei nº 13.146, de 06 de Julho de 2015. Institui a Lei Brasileira de Inclusão da Pessoa com Deficiência (Estatuto da Pessoa com Deficiência). Diário Oficial da República Federativa do Brasil, Brasília (DF)] Avaiable from: http://www.plan-alto.gov.br/ccivil_03/_ato2015-2018/2015/lei/l13146.htmAccessed Jun 20, 2016
   Google Scholar
• BovolentaTMFelicioACHow do demographic transitions and public health policies affect patients with Parkinson’s disease in Brazil?Clin Interv Aging20171219720528182156
   PubMed Web of Science ®Google Scholar
• WangGChengQZhengREconomic burden of Parkinson’s disease in a developing country: a retrospective cost analysis in Shanghai, ChinaMov Disord20062191439144316773620
   PubMed Web of Science ®Google Scholar
• HagellPNordlingSReimerJGrabowskiMPerssonUResource use and costs in a Swedish cohort of patients with Parkinson’s diseaseMov Disord20021761213122012465059
   PubMed Web of Science ®Google Scholar
• FindleyLAujlaMBainPGDirect economic impact of Parkinson’s disease: a research survey in the United KingdomMov Disord200318101139114514534917
   PubMed Web of Science ®Google Scholar
• CuboEMartínez MartinPGonzálezMFradesBmiembros del grupo ELEPImpact of motor and non-motor symptoms on the direct costs of Parkinson’s diseaseNeurologia2009241152319003550
   PubMed Web of Science ®Google Scholar
• VossiusCLarsenJPJanvinCAarslandDThe economic impact of cognitive impairment in Parkinson’s diseaseMov Disord20112681541154421538519
   PubMed Web of Science ®Google Scholar
• BradburnNMRipsLJShevellSKAnswering autobiographical questions: the impact of memory and inference on surveysScience198723647981571613563494
   PubMed Web of Science ®Google Scholar